Artal Group S.A. Gilead Sciences, Inc. Call Options Transaction History

Artal Group S.A.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $91.1 Million - $111 Million	-1,250,000 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $71.2 Million - $83.5 Million	1,000,000 Added 400.0%	1,250,000 $89.6 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $18 Million - $21.4 Million	250,000	250,000 $20.3 Million

1,926

993M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.